Variant report

Variant	esv3442682
Chromosome Location	chr11:74019804-74024402
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:224)
CpG islands
(count:675)
Chromatin interactive
region (count:1)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:224 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr11:74022170-74022683	H1-hESC	embryonic stem cell:	n/a	n/a
2	BCL3	chr11:74021828-74022239	GM12878	blood:	n/a	n/a
3	BHLHE40	chr11:74022515-74022585	K562	blood:	n/a	n/a
4	CCNT2	chr11:74022381-74022807	K562	blood:	n/a	n/a
5	CEBPB	chr11:74023438-74023800	MCF-7	breast:	n/a	chr11:74023581-74023592
6	CEBPB	chr11:74023456-74023744	H1-hESC	embryonic stem cell:	n/a	chr11:74023581-74023592
7	CEBPB	chr11:74023395-74023856	A549	lung:	n/a	chr11:74023816-74023829 chr11:74023581-74023592
8	CEBPB	chr11:74023406-74023802	IMR90	lung:	n/a	chr11:74023581-74023592
9	CEBPB	chr11:74023398-74023778	HepG2	liver:	n/a	chr11:74023581-74023592
10	CEBPB	chr11:74023466-74023693	HepG2	liver:	n/a	chr11:74023581-74023592
11	CEBPB	chr11:74023396-74023801	A549	lung:	n/a	chr11:74023581-74023592
12	CEBPB	chr11:74023394-74023814	Hela-S3	cervix:	n/a	chr11:74023581-74023592
13	CEBPB	chr11:74023423-74023752	K562	blood:	n/a	chr11:74023581-74023592
14	CEBPB	chr11:74023429-74023756	HepG2	liver:	n/a	chr11:74023581-74023592
15	CEBPB	chr11:74023386-74023824	A549	lung:	n/a	chr11:74023581-74023592
16	CHD2	chr11:74022511-74022519	K562	blood:	n/a	n/a
17	CREB1	chr11:74022408-74022845	A549	lung:	n/a	n/a
18	CTCF	chr11:74022400-74022550	GM12875	blood:	n/a	n/a
19	CTCF	chr11:74022568-74022574	MCF-7	breast:	n/a	n/a
20	CTCF	chr11:74022200-74022350	WERI-Rb-1	eye:	n/a	n/a
21	CTCF	chr11:74022420-74022570	WERI-Rb-1	eye:	n/a	n/a
22	CTCF	chr11:74022520-74022670	GM12868	blood:	n/a	n/a
23	CTCF	chr11:74022600-74022750	HPAF	blood vessel:	n/a	n/a
24	CTCF	chr11:74022420-74022570	SAEC	small airway:	n/a	n/a
25	CTCF	chr11:74022540-74022690	AoAF	blood vessel:	n/a	n/a
26	CTCF	chr11:74022383-74022384	MCF-7	breast:	n/a	n/a
27	CTCF	chr11:74022304-74022362	MCF-7	breast:	n/a	n/a
28	CTCF	chr11:74022500-74022650	HMF	breast:	n/a	n/a
29	CTCF	chr11:74022599-74022755	K562	blood:	n/a	n/a
30	CTCF	chr11:74022460-74022610	AG10803	skin:	n/a	n/a
31	CTCF	chr11:74022580-74022730	SK-N-SH_RA	brain:	n/a	n/a
32	CTCF	chr11:74022470-74022734	A549	lung:	n/a	n/a
33	CTCF	chr11:74022460-74022610	HRPEpiC	eye:	n/a	n/a
34	CTCF	chr11:74022440-74022590	HUVEC	blood vessel:	n/a	n/a
35	CTCF	chr11:74022420-74022570	HCT-116	colon:	n/a	n/a
36	CTCF	chr11:74022520-74022670	HCPEpiC	choroid plexus:	n/a	n/a
37	CTCF	chr11:74022560-74022710	GM12869	blood:	n/a	n/a
38	CTCF	chr11:74022480-74022630	GM12873	blood:	n/a	n/a
39	CTCF	chr11:74022500-74022770	HVMF	connective:	n/a	n/a
40	CTCF	chr11:74020362-74020639	H1-hESC	embryonic stem cell:	n/a	chr11:74020506-74020515
41	CTCF	chr11:74022417-74022863	K562	blood:	n/a	n/a
42	CTCF	chr11:74022440-74022590	HAc	cerebellar:	n/a	n/a
43	CTCF	chr11:74022400-74022690	GM12864	blood:	n/a	n/a
44	CTCF	chr11:74022520-74022670	HPAF	blood vessel:	n/a	n/a
45	CTCF	chr11:74022500-74022650	NHEK	skin:	n/a	n/a
46	CTCF	chr11:74022400-74022550	HEEpiC	esophagus:	n/a	n/a
47	CTCF	chr11:74022480-74022630	HEK293	kidney:	n/a	n/a
48	CTCF	chr11:74022500-74022650	SK-N-SH_RA	brain:	n/a	n/a
49	CTCF	chr11:74022440-74022590	WERI-Rb-1	eye:	n/a	n/a
50	CTCF	chr11:74022540-74022690	HCT-116	colon:	n/a	n/a

(count:675 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:74022930-74022980	NHDF-neo	bronchial:	n/a
2	chr11:74022477-74022527	HepG2	liver:	n/a
3	chr11:74022764-74022814	GM12878	blood:	n/a
4	chr11:74022882-74022932	GM12878	blood:	n/a
5	chr11:74022930-74022980	NHDF-neo	bronchial:	n/a
6	chr11:74022477-74022527	HepG2	liver:	n/a
7	chr11:74022764-74022814	GM12878	blood:	n/a
8	chr11:74022882-74022932	GM12878	blood:	n/a
9	chr11:74022477-74022527	CMK	blood:	n/a
10	chr11:74023050-74023100	PrEC	prostate:	n/a
11	chr11:74022742-74022792	HepG2	liver:	n/a
12	chr11:74022910-74022960	HL-60	blood:	n/a
13	chr11:74022882-74022932	AG09319	gingival:	n/a
14	chr11:74022910-74022960	HRPEpiC	eye:	n/a
15	chr11:74022477-74022527	PANC-1	pancreas:	n/a
16	chr11:74022930-74022980	SAEC	small airway:	n/a
17	chr11:74022875-74022925	RPTEC	kidney:	n/a
18	chr11:74022875-74022925	HCT-116	colon:	n/a
19	chr11:74022882-74022932	RPTEC	kidney:	n/a
20	chr11:74023050-74023100	SK-N-SH_RA	brain:	n/a
21	chr11:74022477-74022527	K562	blood:	n/a
22	chr11:74023050-74023100	PFSK-1	brain:	n/a
23	chr11:74022910-74022960	Caco-2	colon:	n/a
24	chr11:74022558-74022608	HIPEpiC	eye:	n/a
25	chr11:74022348-74022398	AG10803	skin:	n/a
26	chr11:74022882-74022932	AG10803	skin:	n/a
27	chr11:74022348-74022398	HRPEpiC	eye:	n/a
28	chr11:74022930-74022980	HCF	heart:	n/a
29	chr11:74022882-74022932	LNCaP	prostate:	n/a
30	chr11:74022764-74022814	GM12892	blood:	n/a
31	chr11:74022764-74022814	BE2_C	brain:	n/a
32	chr11:74022910-74022960	PFSK-1	brain:	n/a
33	chr11:74023050-74023100	K562	blood:	n/a
34	chr11:74022930-74022980	GM12878	blood:	n/a
35	chr11:74022930-74022980	Jurkat	blood:	n/a
36	chr11:74022910-74022960	SK-N-SH_RA	brain:	n/a
37	chr11:74022558-74022608	GM06990	blood:	n/a
38	chr11:74023050-74023100	NHBE	bronchial:	n/a
39	chr11:74022930-74022980	HRE	kidney:	n/a
40	chr11:74022764-74022814	HIPEpiC	eye:	n/a
41	chr11:74023050-74023100	GM12891	blood:	n/a
42	chr11:74022348-74022398	GM12892	blood:	n/a
43	chr11:74022882-74022932	SK-N-MC	brain:	n/a
44	chr11:74022930-74022980	GM06990	blood:	n/a
45	chr11:74022882-74022932	HCF	heart:	n/a
46	chr11:74023050-74023100	Hepatocyte	liver:	n/a
47	chr11:74022477-74022527	SK-N-MC	brain:	n/a
48	chr11:74023050-74023100	BJ	skin:	n/a
49	chr11:74022764-74022814	IMR90	lung:	fetal
50	chr11:74022882-74022932	GM19239	blood:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr11:74019898..74022281-chr11:74031863..74033488,2	K562	blood:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PPME1-1	chr11:74022870-74022991	ENSG00000246211
2	lnc-PPME1-1	chr11:74022407-74022494	ENSG00000246211
3	lnc-PPME1-1	chr11:74023164-74023264	ENSG00000246211

No data

Variant related genes	Relation type
ENSG00000246211	TF binding region
P4HA3	TF binding region
ENSG00000246211	CpG island
P4HA3	CpG island
ARF3	miRNA target sites
HNRNPA2B1	miRNA target sites

Extended variants
information (count: 143 )
Associated
traits (count: 102 )

Variant overlapped rSNPs/rCNVs (count:143 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs570706842	chr11:74019834-74019835	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs539826953	chr11:74019864-74019865	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs536201312	chr11:74019895-74019896	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs181423691	chr11:74019909-74019910	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs140323615	chr11:74019920-74019921	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs555577814	chr11:74019923-74019924	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs185957221	chr11:74019925-74019926	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs373416294	chr11:74019932-74019933	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs190874950	chr11:74019933-74019934	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs539915073	chr11:74020014-74020015	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs560198273	chr11:74020022-74020023	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs576722909	chr11:74020034-74020035	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs545826434	chr11:74020042-74020043	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs568392114	chr11:74020073-74020074	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs183872685	chr11:74020116-74020117	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs535390679	chr11:74020144-74020145	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs375570099	chr11:74020178-74020179	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs561115844	chr11:74020181-74020182	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs11236049	chr11:74020194-74020195	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs548518468	chr11:74020236-74020237	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs561837344	chr11:74020338-74020339	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs550556129	chr11:74020348-74020349	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs547531686	chr11:74020367-74020368	Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs188817412	chr11:74020386-74020387	Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs539445701	chr11:74020470-74020471	Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs550174848	chr11:74020486-74020487	Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs191052707	chr11:74020529-74020530	Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs77313929	chr11:74020536-74020537	Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs182878438	chr11:74020545-74020546	Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs528486956	chr11:74020556-74020557	Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs187475509	chr11:74020560-74020561	Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs554495706	chr11:74020571-74020572	Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs376209197	chr11:74020618-74020619	Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs74903268	chr11:74020651-74020652	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs4362166	chr11:74020773-74020774	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs145375261	chr11:74020774-74020775	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs557918668	chr11:74020841-74020842	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs200894447	chr11:74020843-74020844	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs562468889	chr11:74020851-74020852	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs576128071	chr11:74020887-74020888	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs566940991	chr11:74020916-74020917	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs191615704	chr11:74020981-74020982	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs561502	chr11:74021016-74021017	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs561970056	chr11:74021044-74021045	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs534448337	chr11:74021045-74021046	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs527471001	chr11:74021049-74021050	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs115268030	chr11:74021077-74021078	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs564400871	chr11:74021094-74021095	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs533503056	chr11:74021157-74021158	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs555684602	chr11:74021205-74021206	Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:102)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Autism	22495311	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Glioblastoma multiforme	21138945	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	18632612	CNVD
Smith-Lemli-Opitz syndrome	21572526	CNVD
Glioblastoma multiforme	21080181	CNVD
Multiple myeloma	16461302	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chordoma	21602918	CNVD
Metanephric adenoma	20802469	CNVD
Melanoma	18172304	CNVD
Breast cancer	21806811	CNVD
Breast cancer	22002566	CNVD
Ductal carcinoma	18381933	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20953835	CNVD
oto-dental syndrome	17656375	CNVD
Asthma	21956041	CNVD
Breast cancer	17603634	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	20864512	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21509527	CNVD
Breast cancer	17001317	CNVD
Oral squamous cell carcinoma	16619035	CNVD
Intracranial aneurysm	16715129	CNVD
Colorectal cancer	16272173	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Colorectal cancer	16882699	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668395	CNVD
Spinal muscular atrophy	17668395	CNVD
Neonatal seizures	17668395	CNVD
Neonatal seizures	17668391	CNVD
Neuroticism	17667963	CNVD
Cancer	17916600	CNVD
Squamous cell cancer	19047905	CNVD
Multiple endocrine neoplasia type 1	19566914	CNVD
XY sex reversal	17503084	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668391	CNVD
Maculopathy	17646752	CNVD
Breast cancer	17899364	CNVD
Breast cancer	17157792	CNVD
Esophageal squamous carcinoma	18350619	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
lymphocytic leukemia	21291569	CNVD
Myelofibrosis	22110671	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Breast cancer	21364760	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Breast cancer	16620391	CNVD
Multiple myeloma	17550852	CNVD
Neuroblastoma	18923191	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Multiple myeloma	16616336	CNVD
Urothelial cell carcinoma	18451213	CNVD
Leukoplakia	24403051	CNVD
Prostate cancer	17217626	CNVD
Cancer	22429812	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	21251322	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:340 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:73999800-74022200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr11:74017600-74020200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
3	chr11:74018800-74022200	Weak transcription	NHLF	lung
4	chr11:74019000-74021800	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
5	chr11:74019000-74021800	Weak transcription	HSMM	muscle
6	chr11:74019000-74021800	Weak transcription	HUVEC	blood vessel
7	chr11:74019000-74021800	Weak transcription	NH-A	brain
8	chr11:74019000-74022000	Weak transcription	Fetal Heart	heart
9	chr11:74019000-74022200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
10	chr11:74019200-74021400	Weak transcription	Muscle Satellite Cultured Cells	--
11	chr11:74019400-74022000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
12	chr11:74019600-74020200	Weak transcription	A549	lung
13	chr11:74019600-74021200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
14	chr11:74019600-74021800	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
15	chr11:74019600-74022000	Weak transcription	Osteobl	bone
16	chr11:74020200-74020800	Enhancers	A549	lung
17	chr11:74020200-74022400	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
18	chr11:74020800-74021200	Flanking Active TSS	A549	lung
19	chr11:74021200-74021600	Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
20	chr11:74021200-74021600	Active TSS	A549	lung
21	chr11:74021400-74021600	Active TSS	Muscle Satellite Cultured Cells	--
22	chr11:74021600-74022200	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
23	chr11:74021600-74022400	Bivalent Enhancer	Primary B cells from peripheral blood	blood
24	chr11:74021600-74022400	Flanking Active TSS	Muscle Satellite Cultured Cells	--
25	chr11:74021600-74022400	Flanking Active TSS	A549	lung
26	chr11:74021600-74023000	Flanking Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
27	chr11:74021800-74022000	Flanking Bivalent TSS/Enh	Primary T cells from cord blood	blood
28	chr11:74021800-74022000	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
29	chr11:74021800-74022000	Bivalent/Poised TSS	Fetal Lung	lung
30	chr11:74021800-74022200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
31	chr11:74021800-74022200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
32	chr11:74021800-74022200	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
33	chr11:74021800-74022200	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
34	chr11:74021800-74022200	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
35	chr11:74021800-74022200	Bivalent/Poised TSS	Colon Smooth Muscle	Colon
36	chr11:74021800-74022200	Bivalent Enhancer	Fetal Kidney	kidney
37	chr11:74021800-74022200	Enhancers	Pancreas	Pancrea
38	chr11:74021800-74022200	Enhancers	Placenta Amnion	Placenta Amnion
39	chr11:74021800-74022200	Active TSS	Psoas Muscle	Psoas
40	chr11:74021800-74022200	Bivalent Enhancer	Rectal Mucosa Donor 31	rectum
41	chr11:74021800-74022200	Bivalent/Poised TSS	NHEK	skin
42	chr11:74021800-74022400	Flanking Active TSS	HUVEC	blood vessel
43	chr11:74021800-74022400	Flanking Active TSS	NH-A	brain
44	chr11:74021800-74023000	Active TSS	HSMM	muscle
45	chr11:74021800-74023200	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
46	chr11:74021800-74023200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
47	chr11:74022000-74022200	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
48	chr11:74022000-74022200	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
49	chr11:74022000-74022200	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
50	chr11:74022000-74022200	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links